戻る Agenda
Break Out Sessions 2B: Data Quality, Governance and Sharing – Enabling Insights and Decision Making
Session Chair(s)
Patrick Brady, PharmD
Global Head, Therapeutic Innovation & Regulatory Science
IQVIA, United States
Advancements in technology and the amount of data generated from an increasing number of data sources has led to the proliferation of data brings into the question the capacity to manage the volume, velocity, variety, veracity, and value of data (The 5 V’s of Big Data). Although these advancements have present new challenges for data management and, more specifically, clinical data management, it also presents new opportunities in the form of digital health solutions that support more robust clinical research data through decentralized clinical trials, Real World Data/Evidence, Complex Innovative Design Trials, introduction of wearables and mobile software applications for improved clinical decision and patient decision support
Speaker(s)
Jesper Kjær, MS
Novo Nordisk, Denmark
Global Director for Public, Private Partnerships, Strat Ops, Global Med Affairs
Fiona Maini, MS
Medidata a Dassault Systèmes Company, United Kingdom
Principal Global Compliance and Strategy Principal
Vada Perkins, DrSc, MSc
Boehringer Ingelheim, United States
Vice President, Global Head of Regulatory Intelligence & Policy